Transcode Therapeutics Inc (RNAZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,438 | 16,853 | 20,826 | 22,500 | 80 |
| TOTAL | $13,921 | $18,635 | $22,732 | $25,204 | $540 |
| Non-Current Assets | |||||
| PPE Net | 235 | 215 | 206 | 156 | 92 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 890 |
| TOTAL | $235 | $215 | $206 | $156 | $982 |
| Total Assets | $14,156 | $18,850 | $22,938 | $25,360 | $1,522 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,704 | 1,826 | 2,504 | 1,985 | 1,252 |
| Other current liabilities | N/A | N/A | N/A | N/A | 29 |
| TOTAL | $1,727 | $1,849 | $2,534 | $2,205 | $1,533 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 24 | 24 | 31 | 220 | 252 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 5,025 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $5,025 |
| Total Liabilities | $1,727 | $1,849 | $2,534 | $2,205 | $6,558 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 12,977 | 12,977 | 12,905 | 12,905 | 12,905 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -18,447 | -13,775 | -10,305 | -7,506 | -5,176 |
| Other shareholders' equity | 0 | 0 | 0 | -10 | -9 |
| TOTAL | $12,428 | $17,001 | $20,404 | $23,155 | $-5,036 |
| Total Liabilities And Equity | $14,156 | $18,850 | $22,939 | $25,360 | $1,522 |